Invasive Pseudomonas aeruginosa infections:: high rate of recurrence and mortality after hematopoietic cell transplantation

被引:61
作者
Hakki, M.
Limaye, A. P.
Kim, H. W.
Kirby, K. A.
Corey, L.
Boeckh, M.
机构
[1] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
关键词
Pseudomonas aeruginosa; transplantation; bacterial infection;
D O I
10.1038/sj.bmt.1705653
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Limited data exist regarding the incidence and factors associated with outcome of invasive Pseudomonal infections in hematopoietic cell transplant (HCT). A retrospective analysis of cases of invasive Pseudomonas aeruginosa infection and factors associated with outcome was performed. P. aeruginosa invasive infection occurred in 95 of 5772 patients (1.65%) a median of 63 days after HCT (range 5-1435). Only 28% of infections occurred during periods of neutropenia (absolute neutrophil count <500 cells/mm(3)). Infection-attributable mortality during the initial episode of infection was 35.8%. Factors associated with initial mortality included the presence of a copathogen and high-dose steroid use. Ten (16.4%) of those who survived the initial infection experienced a recurrence of P. aeruginosa infection at a median of 9 days (range 3-17) after stopping antibiotics and 60% of those died as a result of recurrent infection a median of 1 day (range 1-7) after onset of recurrence. Grade 3-4 graft-versus-host disease was associated with a higher risk of recurrent infection. The risk of recurrence was not influenced by the presence of copathogens. Thus, invasive P. aeruginosa infections are associated with high recurrence rates and mortality in this immunocompromised population. Aggressive attempts to reduce immunosuppression and to treat copathogens may help during the initial infection.
引用
收藏
页码:687 / 693
页数:7
相关论文
共 24 条
[1]   Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths A Systematic Review [J].
Mackey, Katherine ;
Ayers, Chelsea K. ;
Kondo, Karli K. ;
Saha, Somnath ;
Advani, Shailesh M. ;
Young, Sarah ;
Spencer, Hunter ;
Rusek, Max ;
Anderson, Johanna ;
Veazie, Stephanie ;
Smith, Mia ;
Kansagara, Devan .
ANNALS OF INTERNAL MEDICINE, 2021, 174 (03) :362-+
[2]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[3]   INCIDENCE AND RISK-FACTORS OF RECURRENT EPISODES OF BACTEREMIA IN ADULTS [J].
CAPDEVILA, JA ;
ALMIRANTE, B ;
PAHISSA, A ;
PLANES, AM ;
RIBERA, E ;
MARTINEZVAZQUEZ, J .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (04) :411-415
[4]   Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients [J].
Collin, BA ;
Leather, HL ;
Wingard, JR ;
Ramphal, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) :947-953
[5]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[6]   Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study [J].
Junghanss, C ;
Marr, KA ;
Carter, RA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Chauncey, T ;
McSweeney, PA ;
Storb, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) :512-520
[7]   ORAL NORFLOXACIN FOR PREVENTION OF GRAM-NEGATIVE BACTERIAL-INFECTIONS IN PATIENTS WITH ACUTE-LEUKEMIA AND GRANULOCYTOPENIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
KARP, JE ;
MERZ, WG ;
HENDRICKSEN, C ;
LAUGHON, B ;
REDDEN, T ;
BAMBERGER, BJ ;
BARTLETT, JG ;
SARAL, R ;
BURKE, PJ .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) :1-7
[8]   CIPROFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OF BACTERIAL-INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS - A RANDOMIZED, CONTROLLED TRIAL [J].
LEW, MA ;
KEHOE, K ;
RITZ, J ;
ANTMAN, KH ;
NADLER, L ;
KALISH, LA ;
FINBERG, R .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :239-250
[9]   BACTERIAL PNEUMONIA IN RECIPIENTS OF BONE-MARROW TRANSPLANTATION - A 5-YEAR PROSPECTIVE STUDY [J].
LOSSOS, IS ;
BREUER, R ;
OR, R ;
STRAUSS, N ;
ELISHOOV, H ;
NAPARSTEK, E ;
AKER, M ;
NAGLER, A ;
MOSES, AE ;
SHAPIRO, M ;
SLAVIN, S ;
ENGELHARD, D .
TRANSPLANTATION, 1995, 60 (07) :672-678
[10]   Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome [J].
Mitchell, AE ;
Derrington, P ;
Turner, P ;
Hunt, LP ;
Oakhill, A ;
Marks, DI .
BONE MARROW TRANSPLANTATION, 2004, 33 (03) :303-310